reference/1972581

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1972581

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Research Support, Non-U.S. Gov't\|Systematic Review
issn	0920-1211
pageRange	106403-
publicationName	Epilepsy Research
startingPage	106403
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7c654c1f9ccb900dd1f4b32cf56e524c
bibliographicCitation	Trinka E, Tsong W, Toupin S, Patten A, Wilson K, Isojarvi J, James D. A systematic review and indirect treatment comparison of perampanel versus brivaracetam as adjunctive therapy in patients with focal-onset seizures with or without secondary generalization. Epilepsy Res. 2020 Oct;166():106403. doi: 10.1016/j.eplepsyres.2020.106403. PMID: 32673969.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c2e356bc0d216783c44e0f5cbb65733 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2399439874d692f23c5b4ecb9cbc89e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5950-2692 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d441ca92a99ead1a1856eb1a3940200 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f63e0fbdee83fb4a257bb9fa5560d8b2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_078460cd9efdabed8bb1670bf5905f53 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_acca687ed337e1cc0dc9bb4dc4d59d2a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9b5aa376bd139e4855f7f7dcd2834f7
date	202010
identifier	https://pubmed.ncbi.nlm.nih.gov/32673969 https://doi.org/10.1016/j.eplepsyres.2020.106403
isPartOf	https://portal.issn.org/resource/ISSN/0920-1211 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	A systematic review and indirect treatment comparison of perampanel versus brivaracetam as adjunctive therapy in patients with focal-onset seizures with or without secondary generalization
discusses	http://id.nlm.nih.gov/mesh/M0014878 http://id.nlm.nih.gov/mesh/M0549034 http://id.nlm.nih.gov/mesh/M0018236 http://id.nlm.nih.gov/mesh/M0497062 http://id.nlm.nih.gov/mesh/M0018278 http://id.nlm.nih.gov/mesh/M0374035 http://id.nlm.nih.gov/mesh/M0001382
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D012640Q000175 http://id.nlm.nih.gov/mesh/D011760Q000008 http://id.nlm.nih.gov/mesh/D012640Q000188 http://id.nlm.nih.gov/mesh/D000927Q000008 http://id.nlm.nih.gov/mesh/D009570Q000008 http://id.nlm.nih.gov/mesh/D011728Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D009570Q000009 http://id.nlm.nih.gov/mesh/D000077287Q000009 http://id.nlm.nih.gov/mesh/D000077287Q000008 http://id.nlm.nih.gov/mesh/D000927Q000009 http://id.nlm.nih.gov/mesh/D012640Q000453 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D016032Q000379 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D011760Q000009 http://id.nlm.nih.gov/mesh/D011728Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9837243 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9924495 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7483 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7620 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284583

Total number of triples: 54.